Skip to content

Clinical efficacy and brain network mechanism of bilateral swallowing cortex combined with suprhyoid iTBS in patients with dysphagia after stroke

Clinical efficacy and brain network mechanism of bilateral swallowing cortex combined with suprhyoid iTBS in patients with dysphagia after stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083503
Enrollment
Unknown
Registered
2024-04-26
Start date
2024-04-29
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Suprahyoid muscle iTBS group:iTBS stimulation: stimulation intensity 100% RMT, each pulse contains 3 continuous pulses, 50Hz, 5Hz, each cluster for 2s, 8s interval, total time 192s, total stimulation
false stimulation: flip coil, treatment site, treatment parameters, etc
Bilateral swallowing cortical iTBS group:iTBS stimulation: stimulation intensity 100% RMT, each pulse contains 3 continuous pulses, 50Hz, 5Hz, each cluster for 2s, 8s interval, total time 192s, total
Combined stimulation group:iTBS stimulation: stimulation intensity 100% RMT, each pulse contains 3 continuous pulses, 50Hz, 5Hz, each cluster for 2s, 8s interval, total time 192s, total stimulation pu

Sponsors

The Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Unilateral stroke (hemorrhagic (without craniotomy), ischemic) meeting stroke diagnostic criteria; (CT or MRI confirmation, reserved for further subgroup analysis); (2) First onset, 2 weeks =3 level; (6) The family members or the patient himself shall sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: (1) Swallowing problems caused by other neurological diseases, such as Parkinson's disease, Alzheimer's disease, motor neuron disease, craniocerebral trauma, cerebellar or brainstem stroke; (2) a history of intractable infectious disease; (3) intracranial metal implants and (or) cardiac metal implants; (4) Vvital signs are unstable or in the acute stage of disease; (5) The patient has poor cognitive function and cannot cooperate with the relevant examination and treatment.

Design outcomes

Primary

MeasureTime frame
standard swallowing function evaluation scale (SSA);

Secondary

MeasureTime frame
Supraphyhyoid group motor evoked potential (MEP);Fiberoptic laryngoscope swallowing function examination (FEES);Functional near-infrared spectroscopy (fNIRS);Functional nuclear magnetic resonance (fMRI);

Countries

China

Contacts

Public ContactBangqiang Hou

The Affiliated Hospital of North Sichuan Medical College

1451298974@qq.com+86 183 8015 8051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026